Both the FDA and the European Medicines Agency are reviewing deucrictibant for approval.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Both the FDA and the European Medicines Agency are reviewing deucrictibant for approval.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
Related events
- Both the FDA and the European Medicines Agency govern drug approval processes.
- Both the FDA and European Medicines Agency must adopt evidence-based principles for drug regulation.
- Alvotech submitted a regulatory application to the European Medicines Agency (EMA).
- enVVeno Medical received IDE approval from the FDA for its pivotal study on July 31, 2026.
- EyePoint Pharmaceuticals developed its LUCIA trial program in alignment with the FDA, with enrollment noted in Lugano.